DNA methylation heterogeneity and dynamics hinder distinguishing early pathological changes from normal variation. Here, the authors identify stable sites whose disruption is linked to blood cancers, aging, and cardiovascular risk.
- Salman Basrai
- Ido Nofech-Mozes
- Sagi Abelson
